<!DOCTYPE html>
<html lang="en-us">
  <head>
	<meta name="generator" content="Hugo 0.85.0" />
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    
    <title>fallingstar-Daily-rss | Fallingstar Daily R</title>
    <link rel="stylesheet" href="/css/style.css" />
    <link rel="stylesheet" href="/css/fonts.css" />
    <link href="//cdn.bootcss.com/highlight.js/9.12.0/styles/github.min.css" rel="stylesheet">

  </head>

  <body>
    <nav class="header">
      <div class="banner">
<a href="/" class="text">
&Ffr;&Afr;&Lfr;&Lfr;&Ifr;&Nfr;&Gfr;&Sfr;&Tfr;&Afr;&Rfr; &Dfr;&Afr;&Ifr;&Lfr;&Yfr; &Rfr;
</a>
</div>

      <div class="head-meta">
      
        <span>fallingstar-Daily-rss</span>
        <span>2024-11-26</span>
      
      </div>
    </nav>


<div class="container">
<main class="list">

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39587331/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241126171718&amp;v=2.18.0.post9&#43;e462414">Non-exudative OCT findings in neovascular AMD</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39587331-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241126171718-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    In this narrative review we describe the main optical coherence tomography biomarkers appearing in eyes with neovascular age-related macular degeneration (AMD) that do not directly correspond to exudation. We highlight those signs that may mimic exudation and therefore do not require active treatment, such as outer retinal tubulations, pseudocysts, lipid globules, or hyporeflective wedges. Other signs may indicate impending exudation such as hyperreflective foci or shallow irregular &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39587361/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241126171718&amp;v=2.18.0.post9&#43;e462414">Single-cell multiomics analysis reveals dynamic clonal evolution and targetable phenotypes in acute myeloid leukemia with complex karyotype</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39587361-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241126171718-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Chromosomal instability is a major driver of intratumoral heterogeneity (ITH), promoting tumor progression. In the present study, we combined structural variant discovery and nucleosome occupancy profiling with transcriptomic and immunophenotypic changes in single cells to study ITH in complex karyotype acute myeloid leukemia (CK-AML). We observed complex structural variant landscapes within individual cells of patients with CK-AML characterized by linear and circular breakage-fusion-bridge&hellip; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39587448/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241126171718&amp;v=2.18.0.post9&#43;e462414">Body mass index at birth and early life and colorectal cancer: A two-sample Mendelian randomization analysis in European and East Asian genetic similarity populations</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39587448-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241126171718-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: We found little evidence of any associations between early life adiposity on later life CRC &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39587707/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241126171718&amp;v=2.18.0.post9&#43;e462414">Fusobacterium nucleatum Abundance is Associated with Cachexia in Colorectal Cancer Patients: The ColoCare Study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39587707-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241126171718-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Our findings suggest that high fecal Fn abundance was associated with an increased risk of cachexia at 6 months post-surgery in CRC patients. This is the first study to link Fn abundance with cachexia in CRC patients, offering novel insights into biological mechanisms and potential management of cancer cachexia. Due to the small sample size, our results should be interpreted with caution. Future studies with larger sample sizes are needed to validate these &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39587921/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241126171718&amp;v=2.18.0.post9&#43;e462414">Genocopy of EVI1-AML with paraneoplastic diabetes insipidus: PRDM16 overexpression by t(1;2)(p36;p21) and enhancer hijacking</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39587921-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241126171718-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Diabetes insipidus (DI) in patients with acute myeloid leukaemia (AML) and chromosome 3q alterations (EVI1/PRDM3/MECOM overexpression) constitutes a poorly understood paraneoplasia. A 44-year-old patient presented with clinical and morphological features of this syndrome but, surprisingly, disclosed the rare translocation t(1;2)(p36;p21), with massive PRDM16 overexpression. WGS and RNA sequencing suggest enhancer hijacking of the ZFP36L2 enhancer region as underlying mechanism. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39588067/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241126171718&amp;v=2.18.0.post9&#43;e462414">Catheter ablation of atrial fibrillation in women with heart failure with preserved ejection fraction</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39588067-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241126171718-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Women with HFpEF constitute a distinct subgroup with high rates of AF-related events after AF-ablation, and persistence of both symptoms and functional hallmarks of HFpEF. Consideration of sex-specific cardiac co-morbidities is crucial for personalization and optimization of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39588282/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241126171718&amp;v=2.18.0.post9&#43;e462414">Upregulated miR-10b-5p as a potential miRNA signature in amyotrophic lateral sclerosis patients</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39588282-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241126171718-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Amyotrophic lateral sclerosis (ALS) is a fatal, adult-onset disease marked by a progressive degeneration of motor neurons (MNs) present in the spinal cord, brain stem and motor cortex. Death in most patients usually occurs within 2-4 years after symptoms onset. Despite promising progress in delineating underlying mechanisms, such as disturbed proteostasis, DNA/RNA metabolism, splicing or proper nucleocytoplasmic shuttling, there are no effective therapies for the vast majority of cases. A &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39588379/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241126171718&amp;v=2.18.0.post9&#43;e462414">Interventional Glaucoma: Improving the Patient-Provider Educational Exchange</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39588379-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241126171718-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Glaucoma treatment is beginning to undergo an evolution, moving away from topical medication-based therapies toward more proactive minimally invasive interventions. This shift towards an &ldquo;interventional glaucoma&rdquo; treatment paradigm has been shown to benefit patients, providers, and society. A key component of effectively implementing this approach is education about the importance of glaucoma diagnosis and treatment, as well as the various treatment modalities available. Such education &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39588887/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241126171718&amp;v=2.18.0.post9&#43;e462414">The Duffy Null Phenotype - Addressing a Source of Discrimination in Cancer Care</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39588887-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241126171718-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39588893/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241126171718&amp;v=2.18.0.post9&#43;e462414">A Good Day</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39588893-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241126171718-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39588894/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241126171718&amp;v=2.18.0.post9&#43;e462414">Anaplasmosis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39588894-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241126171718-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39588897/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241126171718&amp;v=2.18.0.post9&#43;e462414">&#34;Target Trial Emulation&#34; for Observational Studies - Potential and Pitfalls</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39588897-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241126171718-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39589135/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241126171718&amp;v=2.18.0.post9&#43;e462414">Transformation of the HIV treatment cascade for people who inject drugs in Ukraine</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39589135-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241126171718-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    BACKGROUND: Ukraine&rsquo;s HIV epidemic, the second-largest in Europe, is concentrated among people who inject drugs (PWID), primarily opioids. Between 2014 and 2021, Ukraine has scaled up opioid agonist therapies (OAT) &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39589344/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241126171718&amp;v=2.18.0.post9&#43;e462414">MoirÃ© Lattice of Twisted Bilayer Graphene as Template for Non-Covalent Functionalization</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39589344-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241126171718-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    We present a novel approach to achieve spatial variations in the degree of non-covalent functionalization of twisted bilayer graphene (tBLG). The tBLG with twist angles varying between ~5Â° and 7Â° was non-covalently functionalized with 1,4,5,8,9,11-hexaazatriphenylenehexacarbonitrile (HATCN) molecules. Our results show a correlation between the degree of functionalization and the twist angle of tBLG. This correlation was determined through Raman spectroscopy, where areas with larger twist &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39589347/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241126171718&amp;v=2.18.0.post9&#43;e462414">Exposure to Silicone Oil Endotamponades Induces VEGF Antibody Aggregation and Loss of Functionality</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39589347-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241126171718-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Contact to silicone oils induces a major loss of functionality of bevacizumab and trastuzumab. This limits clinical use during silicone oil tamponade. The beneficial effect of adding polysorbate suggests that loss of solubilizer is a likely cause of aggregation. Hydrogels, alternatives for vitreous body replacement, do not impair antibody &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39589370/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241126171718&amp;v=2.18.0.post9&#43;e462414">Standard or Extended Lymphadenectomy for Muscle-Invasive Bladder Cancer</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39589370-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241126171718-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: As compared with standard lymphadenectomy, extended lymphadenectomy did not result in improved disease-free or overall survival among patients with muscle-invasive bladder cancer undergoing radical cystectomy and was associated with higher perioperative morbidity and mortality. (Funded by the National Cancer Institute and the Canadian Cancer Society; SWOG S1011 ClinicalTrials.gov number, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39589371/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241126171718&amp;v=2.18.0.post9&#43;e462414">Aggressive Lymphoma after CD19 CAR T-Cell Therapy</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39589371-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241126171718-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The development of a fatal, clonal, autonomously proliferating CD4-CD8- chimeric antigen receptor (CAR)+ peripheral T-cell lymphoma (PTCL) occurred 1 month after a patient received treatment with tisagenlecleucel for relapsed primary central nervous system lymphoma. The PTCL had a clonal T-cell receptor rearrangement, which was already detectable in the apheresis product for CAR T-cell manufacturing and 7 months earlier for autologous transplantation. Somatic DNMT3A and TET2 mutations in &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39589371/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241126171718&amp;v=2.18.0.post9&#43;e462414">Aggressive Lymphoma after CD19 CAR T-Cell Therapy</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39589371-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241126171718-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The development of a fatal, clonal, autonomously proliferating CD4-CD8- chimeric antigen receptor (CAR)+ peripheral T-cell lymphoma (PTCL) occurred 1 month after a patient received treatment with tisagenlecleucel for relapsed primary central nervous system lymphoma. The PTCL had a clonal T-cell receptor rearrangement, which was already detectable in the apheresis product for CAR T-cell manufacturing and 7 months earlier for autologous transplantation. Somatic DNMT3A and TET2 mutations in &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39589372/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241126171718&amp;v=2.18.0.post9&#43;e462414">Prolonged Grief Disorder</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39589372-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241126171718-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39589373/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241126171718&amp;v=2.18.0.post9&#43;e462414">Chlamydial Proctitis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39589373-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241126171718-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39589374/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241126171718&amp;v=2.18.0.post9&#43;e462414">Avoiding Rash Decisions</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39589374-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241126171718-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39589375/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241126171718&amp;v=2.18.0.post9&#43;e462414">Management of Insomnia</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39589375-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241126171718-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39589376/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241126171718&amp;v=2.18.0.post9&#43;e462414">Management of Insomnia</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39589376-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241126171718-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39589377/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241126171718&amp;v=2.18.0.post9&#43;e462414">Management of Insomnia. Reply</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39589377-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241126171718-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39589378/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241126171718&amp;v=2.18.0.post9&#43;e462414">Acute Abdomen in the Modern Era</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39589378-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241126171718-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39589379/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241126171718&amp;v=2.18.0.post9&#43;e462414">Acute Abdomen in the Modern Era</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39589379-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241126171718-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39589380/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241126171718&amp;v=2.18.0.post9&#43;e462414">Acute Abdomen in the Modern Era. Reply</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39589380-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241126171718-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39589482/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241126171718&amp;v=2.18.0.post9&#43;e462414">Urothelial carcinoma of the upper and lower urinary tract-which risk factors make early detection worthwhile?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39589482-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241126171718-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Urothelial carcinoma is one of the most common malignancies both in Germany and worldwide. Due to the frequent occurrence of late-onset or nonspecific symptoms, carcinomas are often diagnosed at advanced stages. Structured early detection programs have the potential to detect urothelial carcinoma in earlier stages and to improve survival rates. Various risk factors are associated with urothelial carcinoma, most notably tobacco abuse and occupational exposure, as well as genetic disorders such &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39589499/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241126171718&amp;v=2.18.0.post9&#43;e462414">Development and inÂ vitro testing of an orthodontic miniscrew for use in the mandible</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39589499-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241126171718-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: The adapted screw design has no negative influence on primary and fracture stability. Whether the design has a positive effect on the success rates in the mandible must be clarified in further clinical &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39589546/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241126171718&amp;v=2.18.0.post9&#43;e462414">PD-L1 expression and characterization of its carrier macrophages in placentas with acute and specifically post-SARS-CoV-2 infection</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39589546-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241126171718-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    At the beginning of the coronavirus disease 2019 (COVID-19) pandemic, uncertainties about the virus and its dangers during pregnancy caused great uncertainty and fear, especially among pregnant women. New data suggest an increased risk of obstetric complications, including maternal complications, preterm labor, intrauterine growth restriction, hypertensive disorders, stillbirths, gestational diabetes and risk, of neonatal developmental disorders. In addition, preeclampsia (PE)-like &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39589601/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241126171718&amp;v=2.18.0.post9&#43;e462414">Comparing spiritual wellbeing and illness perceptions between cancer patients from culturally and linguistically diverse and those from mainstream backgrounds in Australia</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39589601-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241126171718-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Differences in illness perceptions exist among CALD and Anglo-Australians. Spiritual wellbeing appears linked to more favourable perceptions; however, differential effects emerged among groups, emphasizing the need for culturally tailored interventions to improve &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39589693/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241126171718&amp;v=2.18.0.post9&#43;e462414">Evaluating the reproducibility of a deep learning algorithm for the prediction of retinal age</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39589693-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241126171718-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Recently, a deep learning algorithm (DLA) has been developed to predict the chronological age from retinal images. The Retinal Age Gap (RAG), a deviation between predicted age from retinal images (Retinal Age, RA) and chronological age, correlates with mortality and age-related diseases. This study evaluated the reliability and accuracy of RA predictions and analyzed various factors that may influence them. We analyzed two groups of participants: Intravisit and Intervisit, both imaged by &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1655755343/P255mleFJ">12.8ã€Šæ­£å¸¸æ•…äº‹ã€‹ä¸Šæµ·ç«™ğŸˆ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1655755343-p255mlefj/">
    
    
    
    
    
      
    
    12.8ã€Šæ­£å¸¸æ•…äº‹ã€‹ä¸Šæµ·ç«™ğŸˆ <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1655755343/P25RZCHJu">#æƒ…å…³è¥¿æ¸¸#[æœ‰ç¥¨äº†]ç½‘é¡µé“¾æ¥ - è½¬å‘ @å¼ æ€¡å¾®:&amp;ensp;#æƒ…å…³è¥¿æ¸¸# ä¸€æœ¬æ–°åˆŠç‰© ä¸€ç¯‡å°æ–‡ç« ğŸ“– [å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1655755343-p25rzchju/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted -->#æƒ…å…³è¥¿æ¸¸#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_small_web_default.p">https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_small_web_default.p</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1655755343/P26ZXti16">ğŸ‘€ - è½¬å‘ @ä¸Šæµ·æ–‡è‰ºå‡ºç‰ˆç¤¾:&amp;ensp;#æ¦œå•# ã€Š#è¯—çš„æ¶ˆæ¯ï¼Œè¯—äººçš„æ•…äº‹#ã€‹ã€Š#å²è®°ä»Šè¯»#ã€‹å…¥é€‰#åˆ€é”‹ç§‹å­£æ¦œ#[çˆ±ä½ ][ç¤¼ç‰©]ä¸€éƒ¨çº¸ä¸Šçš„â€œä¸­å›½æ–°è¯—è¯¾â€ã€‚ç”±ä¸‡ç‰©åˆ°è¯è¯­ï¼Œ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1655755343-p26zxti16/">
    
    
    
    
    
      
    
    ğŸ‘€<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@ä¸Šæµ·æ–‡è‰ºå‡ºç‰ˆç¤¾<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->#æ¦œå•#<!-- raw HTML omitted --><!-- raw HTML omitted --> ã€Š&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E8%AF%97%E7%9A%84%E6%B6%88%E6%81%AF%EF%BC%8C%E8%AF%97%E4%BA%BA%E7%9A%84%E6%95%85%E4%BA%8B%23&amp;amp;extparam=%23%E8%AF%97%E7%9A%84%E6%B6%88%E6%81%AF%EF%BC%8C%E8%AF%97%E4%BA%BA%E7%9A%84%E6%95%85%25E">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E8%AF%97%E7%9A%84%E6%B6%88%E6%81%AF%EF%BC%8C%E8%AF%97%E4%BA%BA%E7%9A%84%E6%95%85%E4%BA%8B%23&amp;amp;extparam=%23%E8%AF%97%E7%9A%84%E6%B6%88%E6%81%AF%EF%BC%8C%E8%AF%97%E4%BA%BA%E7%9A%84%E6%95%85%E</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/2103074805/P23UGmCYw">ä¼šå—ä¼šçš„ï¼ˆæ‰æ€ªï¼‰ - è½¬å‘ @çº¢å±±çº¢å±±333å·æœº:&amp;ensp;mop ä¼šä¸€ç›´ä¸€ç›´åœ¨ä¸€èµ·å—ï¼Ÿ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-2103074805-p23ugmcyw/">
    
    
    
    
    
      
    
    ä¼šå—ä¼šçš„ï¼ˆæ‰æ€ªï¼‰<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@çº¢å±±çº¢å±±333å·æœº<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->mop<!-- raw HTML omitted --><!-- raw HTML omitted --> ä¼šä¸€ç›´ä¸€ç›´åœ¨ä¸€èµ·å—ï¼Ÿ <!-- raw HTML omitted -->&lt;/ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/2103074805/P27RAd8Vn">ä»€ä¹ˆå¥½ä¸œè¥¿æ˜¯é•œåƒï¼ï¼ï¼æˆ‘åƒåƒåƒï¼ï¼ï¼ - è½¬å‘ @nami_æ³¢é¢¨å–µå­:&amp;ensp;#mop# #å¨æ“# ä¸å¥½å¥½å¬å¦ˆå¦ˆè¯çš„å°å­©ä¼šè¢«æ€ªå¦ˆå¦ˆæŠ“èµ°ï¼ˆXï¼‰ç”»çš„æˆ‘å¥½çˆ½....æ˜¯ã€å¤©å¤©ç¾éš¾ã€‘çš„å†…...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-2103074805-p27rad8vn/">
    
    
    
    
    
      
    
    ä»€ä¹ˆå¥½ä¸œè¥¿æ˜¯é•œåƒï¼ï¼ï¼æˆ‘åƒåƒåƒï¼ï¼ï¼<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@nami_æ³¢é¢¨å–µå­<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->#mop#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted -->#å¨æ“#<!-- raw HTML omitted --><!-- raw HTML omitted --> ä¸å¥½å¥½å¬å¦ˆå¦ˆè¯çš„å°å­©ä¼šè¢«æ€ªå¦ˆå¦ˆæŠ“èµ°ï¼ˆXï¼‰<!-- raw HTML omitted -->ç”»çš„æˆ‘å¥½çˆ½&hellip;.<!-- raw HTML omitted --><!-- raw HTML omitted -->æ˜¯ã€å¤©å¤©ç¾éš¾ã€‘çš„å†…å®¹å»¶ç”³å’Œå”®è´º&hellip;è°¢è°¢å®¶äººä»¬æˆ‘æ´»äº†20å¤šå¹´ç”»äº†å¥½å‡ ä¸ªç¬¨å„¿ç»“æœç¬¬ä¸€æ¬¡è¿™ä¹ˆå—æ¬¢è¿ï¼ˆé¢¤æŠ–åˆ°æ‰ç¬”ã€‚ã€‚ã€‚ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/2103074805/P287lntGu">ä½ è¯´ç”Ÿå‘½æ˜¯ä¸æ˜¯ä¸€åœºåˆä¸€åœºçš„è½®å›</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-2103074805-p287lntgu/">
    
    
    
    
    
      
    
    ä½ è¯´ç”Ÿå‘½æ˜¯ä¸æ˜¯ä¸€åœºåˆä¸€åœºçš„è½®å›  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/P23eTj7G4">æ˜¨å¤©æ™šé¤ï¼Œä»Šå¤©æ—©é¤ï¼Œéƒ½è®©æˆ‘ä»¬æƒŠå¹ï¼šç¦å·èœå¤ªç¾å‘³å¤ªå¥½åƒ[èµ][èµ][èµ]å–µå¥¶å¥¶å†’äº†ä¸€ç¢—ç»¼åˆèœï¼ˆç‰¡è›æ–‡è›¤é±¼ä¸¸ç‰›è‚‰ä¸¸è˜‘è‡æœ¨è€³ç­‰ï¼‰ï¼Œè®©æˆ‘å»æ”¾è°ƒæ–™ï¼Œé¢å¯¹20å¤šç§è°ƒæ–™ï¼ŒçŠ¹...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-p23etj7g4/">
    
    
    
    
    
      
    
    æ˜¨å¤©æ™šé¤ï¼Œä»Šå¤©æ—©é¤ï¼Œéƒ½è®©æˆ‘ä»¬æƒŠå¹ï¼šç¦å·èœå¤ªç¾å‘³å¤ªå¥½åƒ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img alt=&quot;[èµ]&quot; src=&ldquo;<a href="https://h5.sinaimg.cn/m/emoticon/icon/others/h_zan-44ddc70637.png%22">https://h5.sinaimg.cn/m/emoticon/icon/others/h_zan-44ddc70637.png&quot;</a> style=&ldquo;width:1em; height:1em;&rdquo; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/P25ab1vEf">ä¸‰åŠä¸ƒå··æ˜¯å¤è¡—åŒºï¼Œå¤ªå¤§äº†ï¼Œæˆ‘ä»¬åªè½¬äº†å®«å··ã€å®‰æ°‘å··å’Œéƒå®˜å··ï¼Œå°±ç²¾ç–²åŠ›å°½ï¼Œè·Ÿæ®‹å…µè´¥å°†ä¸€æ ·ã€‚å…³é”®æ˜¯çƒ­é‡æ¶ˆè€—æ®†å°½ï¼Œå¿…é¡»é©¬ä¸Šè¡¥å……æ­£èƒ½é‡ï¼Œå–µå¥¶å¥¶ä¸æƒ³å»æ‰¾å¤§ä¼—ç‚¹è¯„æ¨...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-p25ab1vef/">
    
    
    
    
    
      
    
    ä¸‰åŠä¸ƒå··æ˜¯å¤è¡—åŒºï¼Œå¤ªå¤§äº†ï¼Œæˆ‘ä»¬åªè½¬äº†å®«å··ã€å®‰æ°‘å··å’Œéƒå®˜å··ï¼Œå°±ç²¾ç–²åŠ›å°½ï¼Œè·Ÿæ®‹å…µè´¥å°†ä¸€æ ·ã€‚å…³é”®æ˜¯çƒ­é‡æ¶ˆè€—æ®†å°½ï¼Œå¿…é¡»é©¬ä¸Šè¡¥å……æ­£èƒ½é‡ï¼Œå–µå¥¶å¥¶ä¸æƒ³å»æ‰¾å¤§ä¼—ç‚¹è¯„æ¨èçš„é—½èœé¤é¦†ï¼Œå¥¹è¯´éšä¾¿æ‰¾ä¸€å®¶å§ã€‚äºæ˜¯åˆ°è¿™å®¶è“æ°æ²™èŒ¶é¢ï¼ŒæŒ‰å›¾ç´¢éª¥ï¼ŒæŒ‰ç…§å›¾ç‰‡ç‚¹äº†å§œæ¯é¸­46ï¼Œç‰¡è›ç…25ï¼Œè‚‰ç‡•15ï¼ŒèŠ±ç”Ÿæ±¤8ï¼Œå…±è®¡96å…ƒã€‚ç‰¡è›ç…å¾ˆå¥½åƒï¼Œæ¯”å¤§é˜ªçƒ§å¥½åƒã€‚è‚‰ç‡•ä¹Ÿå¥½åƒï¼Œå…¶å®å°±æ˜¯å°é¦„é¥¨ï¼Œä¸çŸ¥ä¸ºä»€ä¹ˆå«â€œè‚‰ç‡•â€ï¼Ÿ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ç¦å·Â·ä¸‰åŠä¸ƒå··<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sina">https://tvax3.sina</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/P26I0a75P">ä¸‰åŠä¸ƒå··åº”è¯¥æ˜¯æ˜æ¸…æ—¶æœŸç¦å·çš„å¯ŒäººåŒºï¼Œè¾¾å®˜æ˜¾å®¦åŒºï¼Œæ·±å®…å¤§é™¢å¤šï¼Œåäººæ•…å±…ä¹Ÿå¤šï¼Œæ ¹æœ¬ä¸å¯èƒ½çœ‹å®Œã€‚æˆ‘ä»¬é©¬ä¸åœè¹„ã€èµ°é©¬è§‚èŠ±èµ°äº†äº”æ¡å··ï¼Œé‡ç‚¹å‚è§‚äº†å®«å··çš„æ²ˆè‘†æ¡¢æ•…å±…...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-p26i0a75p/">
    
    
    
    
    
      
    
    ä¸‰åŠä¸ƒå··åº”è¯¥æ˜¯æ˜æ¸…æ—¶æœŸç¦å·çš„å¯ŒäººåŒºï¼Œè¾¾å®˜æ˜¾å®¦åŒºï¼Œæ·±å®…å¤§é™¢å¤šï¼Œåäººæ•…å±…ä¹Ÿå¤šï¼Œæ ¹æœ¬ä¸å¯èƒ½çœ‹å®Œã€‚æˆ‘ä»¬é©¬ä¸åœè¹„ã€èµ°é©¬è§‚èŠ±èµ°äº†äº”æ¡å··ï¼Œé‡ç‚¹å‚è§‚äº†å®«å··çš„æ²ˆè‘†æ¡¢æ•…å±…å’Œéƒå®˜å··çš„ä¸¥å¤æ•…å±…ï¼Œå¾ˆæ¶¨å§¿åŠ¿ã€‚ ä¸¤ä½éƒ½æ˜¯è¿‘ä»£æœ‰é‡å¤§å†å²å½±å“çš„åäººï¼Œä¸¤å®¶æ•…å±…éƒ½æ˜¯å›½å®¶é‡ç‚¹æ–‡ç‰©ä¿æŠ¤å•ä½ã€‚æœ‰ä½è²Œä¼¼é€€ä¼‘å¤§å¦ˆçš„æ¸¸å®¢åœ¨æ²ˆè‘†æ¡¢æ•…å±…æƒŠå¹ï¼Œå•Šå•Šï¼Œä»€ä¹ˆæ ·çš„åœ°ä¸»ï¼Œæ‰èƒ½ä¿®è¿™ä¹ˆå¤§çš„æˆ¿å­å“Ÿï¼æˆ‘è¯´ä»€ä¹ˆåœ°ä¸»ï¼Ÿäººå®¶æ˜¯å°ç–†å¤§åå›½å®¶åŠŸè‡£ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/P27JLfDJ3">åˆé¤åï¼Œå–µå¥¶å¥¶å·²ç²¾ç–²åŠ›ç«­ï¼Œå›é…’åº—ä¼‘æ¯ã€‚æˆ‘ç‹¬è‡ªç™»ä¹Œå±±â€”â€”ç¦å·åŸä¸­ä¹‹å±±ï¼Œæ–‡åŒ–ä¹‹å±±ï¼Œé“æ•™ä¹‹å±±ï¼Œæœ‰æ­¦åœ£åº™ã€å•ç¥–å®«ã€æœ±å­ç¥ ç­‰ã€‚æˆ‘æœ€æ„Ÿå…´è¶£çš„æ˜¯æ‘©å´–çŸ³åˆ»ï¼Œä»å”ä»£åˆ°æ˜...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-p27jlfdj3/">
    
    
    
    
    
      
    
    åˆé¤åï¼Œå–µå¥¶å¥¶å·²ç²¾ç–²åŠ›ç«­ï¼Œå›é…’åº—ä¼‘æ¯ã€‚æˆ‘ç‹¬è‡ªç™»ä¹Œå±±â€”â€”ç¦å·åŸä¸­ä¹‹å±±ï¼Œæ–‡åŒ–ä¹‹å±±ï¼Œé“æ•™ä¹‹å±±ï¼Œæœ‰æ­¦åœ£åº™ã€å•ç¥–å®«ã€æœ±å­ç¥ ç­‰ã€‚æˆ‘æœ€æ„Ÿå…´è¶£çš„æ˜¯æ‘©å´–çŸ³åˆ»ï¼Œä»å”ä»£åˆ°æ˜æ¸…ï¼Œæ…¢æ…¢è§‚æ‘©ï¼Œå¾ˆæœ‰éŸµå‘³ã€‚æœ€åä¸€å›¾ï¼Œç¯†ä¹¦ï¼Œæ‰æ˜¯é•‡å±±ä¹‹å®ï¼Œè·ä»Š1200å¤šå¹´ï¼Œå”ä»£å¤§ä¹¦æ³•å®¶æé˜³å†°æ‰€ä¹¦ã€‚è®°å¾—éƒ­æ²«è‹¥ã€Šæç™½ä¸æœç”«ã€‹ä¸­æœ‰è€ƒè¯ï¼Œæé˜³å†°ä¸ºæç™½æ—å”ã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ç¦å·Â·ä¹Œå±±å†å²é£è²Œé£æ™¯åŒº<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/large/d1840ee6gy1hvzx6b4ahsj237k2eo7wk.jpg%22">https://tvax4.sinaimg.cn/large/d1840ee6gy1hvzx6b4ahsj237k2eo7wk.jpg&quot;</a> referrerpolicy=&ldquo;no-referr &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/P27wr8nus">ä¸‰åŠä¸ƒå··æ˜¯æ²¿åå—è¡—å±•å¼€çš„ä¸€å¤§ç‰‡è¡—åŒºï¼Œå›¾1ã€‚æ¼«æ­¥è¡—å··çŸ³æ¿è·¯ï¼Œéšä¾¿ä¸€çœ‹ä¸¤è¾¹å¤§é™¢çš„æ ‡ç‰Œå’Œè¯´æ˜ï¼Œéƒ½æ˜¯ä¸å¯ç§»åŠ¨çš„æ–‡ç‰©ï¼Œå›½å®¶çº§çš„ï¼Œçœçº§çš„ï¼Œå¸‚çº§çš„ï¼Œå½“å¹´çš„ä¸»äººå¤§éƒ½æ˜¯...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-p27wr8nus/">
    
    
    
    
    
      
    
    ä¸‰åŠä¸ƒå··æ˜¯æ²¿åå—è¡—å±•å¼€çš„ä¸€å¤§ç‰‡è¡—åŒºï¼Œå›¾1ã€‚æ¼«æ­¥è¡—å··çŸ³æ¿è·¯ï¼Œéšä¾¿ä¸€çœ‹ä¸¤è¾¹å¤§é™¢çš„æ ‡ç‰Œå’Œè¯´æ˜ï¼Œéƒ½æ˜¯ä¸å¯ç§»åŠ¨çš„æ–‡ç‰©ï¼Œå›½å®¶çº§çš„ï¼Œçœçº§çš„ï¼Œå¸‚çº§çš„ï¼Œå½“å¹´çš„ä¸»äººå¤§éƒ½æ˜¯åé—¨ä¸–å®¶ï¼Œå¤§éƒ½æ˜¯äº›é’å²å¯ä»¥ç•™åçš„äººç‰©ã€‚è¿™æ ·çš„è€è¡—åŒºï¼Œæˆéƒ½æ²¡æœ‰ï¼›é‚£äº›éšè—åœ¨è€è¡—åŒºã€ç»å†å†å²æ²§æ¡‘çš„æ·±å®…å¤§é™¢ï¼Œæˆéƒ½ä¹Ÿæ²¡æœ‰ã€‚è¿™è¯´æ˜æ˜æ¸…æ—¶æœŸï¼Œæˆéƒ½è¿œæ²¡æœ‰ç¦å·å¯Œåº¶ï¼Œè¿œæ²¡æœ‰ç¦å·å‘è¾¾ã€‚ç¦å·çš„å†å²æ–‡åŒ–ç§¯æ·€æ¯”æˆéƒ½æ·±åšå¾—å¤šã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/P27zDBXO5">ç¦å·ä¸‰åŠä¸ƒå··çœŸçš„å¤ªå¥¢ä¾ˆäº†ï¼Œæ´¾å‡ºæ‰€ã€é¤å…å’Œå…¬å•ï¼Œéƒ½è¿™ä¹ˆé›…è‡´ã€‚ ç¦å·Â·ä¸‰åŠä¸ƒå·· [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-p27zdbxo5/">
    
    
    
    
    
      
    
    ç¦å·ä¸‰åŠä¸ƒå··çœŸçš„å¤ªå¥¢ä¾ˆäº†ï¼Œæ´¾å‡ºæ‰€ã€é¤å…å’Œå…¬å•ï¼Œéƒ½è¿™ä¹ˆé›…è‡´ã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ç¦å·Â·ä¸‰åŠä¸ƒå··<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/P23Nl8bpZ">è¾“å…¥ï¼šâ€œæŸ¯æ´å–œæ¬¢æŠŠèˆªæ¯å¼€ç¿»è½¦â€è¾“å‡ºäº†è¿™å¼ å›¾ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-p23nl8bpz/">
    
    
    
    
    
      
    
    è¾“å…¥ï¼šâ€œæŸ¯æ´å–œæ¬¢æŠŠèˆªæ¯å¼€ç¿»è½¦â€<!-- raw HTML omitted -->è¾“å‡ºäº†è¿™å¼ å›¾ <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/P27ftrKVL">é½äº†ï¼Œä½†ç™»å¤©æ–—æŠ€åœº3è®©æˆ‘å‡å¤©äº† [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-p27ftrkvl/">
    
    
    
    
    
      
    
    é½äº†ï¼Œä½†ç™»å¤©æ–—æŠ€åœº3è®©æˆ‘å‡å¤©äº† <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/P27nh1dvG">å°±é—®ä½ æœ‰ä»€ä¹ˆå½±å“ï¼Ÿï¼ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-p27nh1dvg/">
    
    
    
    
    
      
    
    å°±é—®ä½ æœ‰ä»€ä¹ˆå½±å“ï¼Ÿï¼ <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/P28HFhZFh">@æ€¼æ€¼æ¨¡æ‹Ÿå™¨ è¯„ä»·ä¸€ä¸‹æˆ‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-p28hfhzfh/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->@æ€¼æ€¼æ¨¡æ‹Ÿå™¨<!-- raw HTML omitted --> è¯„ä»·ä¸€ä¸‹æˆ‘  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/P258g7yno">çœŸå¥½å•Šï¼Œéƒ½æ¯•ä¸šäº†è·¯é¢é›»è»Šã®è¡—</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-p258g7yno/">
    
    
    
    
    
      
    
    çœŸå¥½å•Šï¼Œéƒ½æ¯•ä¸šäº†<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->è·¯é¢é›»è»Šã®è¡—<!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/P25bRkZN5">æˆ‘å¦ˆä»¥ä¸ºæˆ‘åªæœ‰å‘¨æ—¥æ”¾å‡é‚£å¤©æ‰“æ¸¸æˆå®é™…ä¸Šæˆ‘æ¯å¤©æ™šä¸Šéƒ½åœ¨æ‰“æ¸¸æˆå¹¶ä¸”æˆ‘çˆ±æ‰“ä¸æ‰“[å¼€æ‘†]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-p25brkzn5/">
    
    
    
    
    
      
    
    æˆ‘å¦ˆä»¥ä¸ºæˆ‘åªæœ‰å‘¨æ—¥æ”¾å‡é‚£å¤©æ‰“æ¸¸æˆ<!-- raw HTML omitted -->å®é™…ä¸Šæˆ‘æ¯å¤©æ™šä¸Šéƒ½åœ¨æ‰“æ¸¸æˆå¹¶ä¸”æˆ‘çˆ±æ‰“ä¸æ‰“<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/P25y2hADB">å¥½é¥¿å¥½é¥¿</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-p25y2hadb/">
    
    
    
    
    
      
    
    å¥½é¥¿å¥½é¥¿  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/P2bpQ5mge">è½¬å‘å¾®åš - è½¬å‘ @åƒè‘‰é±¿é±¼:&amp;ensp;ä¹ƒæœ¨å‚46 37th ã€Œæ­©é“æ©‹ã€MV è§£ç¦èµ„è®¯ åƒè‘‰é±¿é±¼çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-p2bpq5mge/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@åƒè‘‰é±¿é±¼<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹ƒæœ¨å‚46<!-- raw HTML omitted --><!-- raw HTML omitted --> 37th ã€Œæ­©é“æ©‹ã€MV è§£ç¦èµ„è®¯ <!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/P29KC9lw4">ä¹…ä¿å²ç»ªé‡Œ ã€Œè¢«æœªæ¥çš„æˆ‘æš´å‡»ã€ EP.26 é¡¶ç­†TENä½¿çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-p29kc9lw4/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->ã€Œè¢«æœªæ¥çš„æˆ‘æš´å‡»ã€ EP.26 <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/2015/0">https://h5.sinaimg.cn/upload/2015/0</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/P29pAByZD">ä¹…ä¿å²ç»ªé‡Œ via.nhk_dramas [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-p29pabyzd/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --> via.nhk_dramas <!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/large/006z6nxLgy1hw0502n6ifj30qo0">https://tvax4.sinaimg.cn/large/006z6nxLgy1hw0502n6ifj30qo0</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39582318/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241125170918&amp;v=2.18.0.post9&#43;e462414">Physician Preferences in Using Novel Digital Devices for the Management of Atrial Fibrillation-A DAS-CAM III Survey</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39582318-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241125170918-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: While PPG-based digital devices are rarely used for diagnosis and screening for AF, intermittent ECG-based digital devices are beginning to be implemented in clinical practice. More education on the potential of novel digital devices is required to achieve diagnostic pathways as suggested by the EHRA practical &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39582349/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241125170918&amp;v=2.18.0.post9&#43;e462414">Survodutide, a glucagon receptor/glucagon-like peptide-1 receptor dual agonist, improves blood pressure in adults with obesity: A post hoc analysis from a randomized, placebo-controlled, dose-finding, phase 2 trial</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39582349-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241125170918-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39582373/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241125170918&amp;v=2.18.0.post9&#43;e462414">Proteomic analysis of non-muscle invasive and muscle invasive bladder cancer highlights distinct subgroups with metabolic, matrisomal, and immune hallmarks and emphasizes importance of the stromal compartment</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39582373-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241125170918-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    We present the proteomic profiling of 79 bladder cancers, including treatment-naÃ¯ve non-muscle-invasive bladder cancer (NMIBC, n = 17), muscle-invasive bladder cancer (MIBC, n = 51), and neoadjuvant-treated MIBC (n = 11). Proteins were extracted from formalin-fixed, paraffin-embedded samples and analyzed using data-independent acquisition, yielding &gt;8,000 quantified proteins. MIBC, compared to NMIBC, shows an extracellular matrix (ECM) and immune response signature as well as alteration of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39582524/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241125170918&amp;v=2.18.0.post9&#43;e462414">Inter-site comparability of 4D flow cardiovascular magnetic resonance measurements in healthy traveling volunteers-a multi-site and multi-magnetic field strength study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39582524-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241125170918-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Basic and advanced hemodynamic parameters revealed equivalency at different sites and field strength in the ascending aorta, a clinically important region of interest, under a highly controlled &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39582811/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241125170918&amp;v=2.18.0.post9&#43;e462414">Treatment-related survival patterns in diffuse intrinsic pontine glioma using a historical cohort: A report from the European Society for Pediatric Oncology DIPG/DMG Registry</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39582811-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241125170918-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: This study shows increased survival outcomes associated with radiation and chemotherapy treatment or a combination thereof, at diagnosis and relapse, in a historical DIPG &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39582830/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241125170918&amp;v=2.18.0.post9&#43;e462414">Investigation of the Mutations in the SARS-CoV-2 Envelope Protein and Its Interaction with the PALS1 by Molecular Docking</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39582830-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241125170918-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: These mutations insert some new helix structures in the E mutants. Also, the results of molecular docking studies indicated that both S68F and L73F mutations could notably enhance the stability and binding affinity of protein E&rsquo;s C-terminal motif to the Protein Associated with LIN7 1, MAGUK P55 Family Member (PALS1) which may probably increase local viral spread, and infiltration of immune cells into lung alveolar &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39582836/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241125170918&amp;v=2.18.0.post9&#43;e462414">Investigation of cefiderocol resistance prevalence and resistance mechanisms in carbapenem-resistant &lt;em&gt;Pseudomonas aeruginosa&lt;/em&gt;, Germany 2019-21</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39582836-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241125170918-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Our findings show the low prevalence of cefiderocol resistance among CR-Pa isolates, showing its potential as an effective treatment option. However, the complex genetic landscape of resistance mechanisms, particularly mutations affecting iron transport and other TonB-dependent receptors, requires continuous monitoring and functional analyses to identify and manage potential resistance mechanisms. This study provides a foundation for future research to improve &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39582879/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1byXLWG-5Hn0_qdLgZYpDfLA2UWGhGNgZGereuo1rJN2aoAQXP&amp;fc=20220814223158&amp;ff=20241125170909&amp;v=2.18.0.post9&#43;e462414">Artificial Intelligence Applications in Lymphoma Diagnosis and Management: Opportunities, Challenges, and Future Directions</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39582879-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1byxlwg-5hn0-qdlgzypdfla2uwghgngzgereuo1rjn2aoaqxp-fc-20220814223158-ff-20241125170909-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Lymphoma, a heterogeneous group of blood cancers, presents significant diagnostic and therapeutic challenges due to its complex subtypes and variable clinical outcomes. Artificial intelligence (AI) has emerged as a promising tool to enhance the accuracy and efficiency of lymphoma pathology. This review explores the potential of AI in lymphoma diagnosis, classification, prognosis prediction, and treatment planning, as well as addressing the challenges and future directions in this &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39582879/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1byXLWG-5Hn0_qdLgZYpDfLA2UWGhGNgZGereuo1rJN2aoAQXP&amp;fc=20220814223158&amp;ff=20241126171707&amp;v=2.18.0.post9&#43;e462414">Artificial Intelligence Applications in Lymphoma Diagnosis and Management: Opportunities, Challenges, and Future Directions</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39582879-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1byxlwg-5hn0-qdlgzypdfla2uwghgngzgereuo1rjn2aoaqxp-fc-20220814223158-ff-20241126171707-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Lymphoma, a heterogeneous group of blood cancers, presents significant diagnostic and therapeutic challenges due to its complex subtypes and variable clinical outcomes. Artificial intelligence (AI) has emerged as a promising tool to enhance the accuracy and efficiency of lymphoma pathology. This review explores the potential of AI in lymphoma diagnosis, classification, prognosis prediction, and treatment planning, as well as addressing the challenges and future directions in this &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39583096/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241125170918&amp;v=2.18.0.post9&#43;e462414">Use of artificial intelligence for liver diseases: A survey from the EASL congress 2024</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39583096-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241125170918-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Artificial intelligence (AI) methods enable humans to analyse large amounts of data, which would otherwise not be feasibly quantifiable. This is especially true for unstructured visual and textual data, which can contain invaluable insights into disease. The hepatology research landscape is complex and has generated large amounts of data to be mined. Many open questions can potentially be addressed with existing data through AI methods. However, the field of AI is sometimes obscured by &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39583332/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241125170918&amp;v=2.18.0.post9&#43;e462414">Solitary fibrous tumor of the prostate with accompanying low-grade prostate cancer</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39583332-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241125170918-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    We present the rare case of a 51-year-old male diagnosed with a solitary fibrous tumor (SFT) of the prostate, along with a concurrent low-grade prostate adenocarcinoma (Gleason score 3 + 3, Grade Group 1). The diagnosis was confirmed by positive immunohistochemical markers, including CD34, BCL2, and STAT6, and molecular analysis showing a NAB2-STAT6 fusion. Following successful surgical management and the simultaneous diagnosis of a pulmonary relapse from a prior thyroid carcinoma, the &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39583885/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241125170918&amp;v=2.18.0.post9&#43;e462414">Advertising of tobacco and related products on social media in Germany</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39583885-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241125170918-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39584027/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241125170918&amp;v=2.18.0.post9&#43;e462414">Primary delayed gastric emptying after pylorus-resecting pancreatoduodenectomy: A matched-pair comparison of Roux-en-Y vs. Billroth-II reconstruction</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39584027-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241125170918-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Primary DGE did not differ between Roux-en-Y and Billroth-II reconstruction after PrPD. Instead, age and postoperative pancreatic biochemical leak were associated with higher DGE &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39584075/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241125170918&amp;v=2.18.0.post9&#43;e462414">Expanding the spectrum of novel candidate genes using trio exome sequencing and identification of monogenic cause in 27.5% of 320 families with steroid-resistant nephrotic syndrome</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39584075-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241125170918-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39584405/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241125170918&amp;v=2.18.0.post9&#43;e462414">Dynamic remodelling of the endoplasmic reticulum for mitosis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39584405-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241125170918-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The endoplasmic reticulum (ER) is a dynamic and continuous membrane network with roles in many cellular processes. The importance and maintenance of ER structure and function have been extensively studied in interphase cells, yet recent findings also indicate crucial roles of the ER in mitosis. During mitosis, the ER is remodelled significantly with respect to composition and morphology but persists as a continuous network. The ER interacts with microtubules, actin and intermediate &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39584494/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241125170918&amp;v=2.18.0.post9&#43;e462414">Exploring personality correlates of falsification of COVID-19 lateral flow tests through vignettes</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39584494-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241125170918-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Regular testing using rapid antigen lateral flow tests (LFTs) was an important prevention strategy during the COVID-19 pandemic. However, falsification of home LFTs was a concern. Using a large quota-representative sample of adults (n = 1295) in England, we conducted a vignette survey consisting of four hypothetical scenarios of LFT falsification behaviours (FBs) to examine whether prosocial personality traits were associated with attitudes towards and intentions for falsifying home LFTs &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39584594/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241125170918&amp;v=2.18.0.post9&#43;e462414">Real-time monitoring of vancomycin using a split-aptamer surface plasmon resonance biosensor</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39584594-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241125170918-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Real-time monitoring of therapeutic drugs is crucial for treatment management and pharmacokinetic studies. We present the optimization and affinity tuning of split-aptamer sandwich assay for real-time monitoring of the narrow therapeutic window drug vancomycin, using surface plasmon resonance (SPR). To achieve reversible, label-free sensing of small molecules by SPR, we adapted a vancomycin binding aptamer in a sandwich assay format through the split-aptamer approach. By evaluating &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39584702/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1x5bM_TNL8gjogAcnslpo2s2PbDe-61JVM2h9yowOYSiZ7Dkrt&amp;fc=20220919211934&amp;ff=20241125170916&amp;v=2.18.0.post9&#43;e462414">BioDSNN: a dual-stream neural network with hybrid biological knowledge integration for multi-gene perturbation response prediction</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39584702-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1x5bm-tnl8gjogacnslpo2s2pbde-61jvm2h9yowoysiz7dkrt-fc-20220919211934-ff-20241125170916-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Studying the outcomes of genetic perturbation based on single-cell RNA-seq data is crucial for understanding genetic regulation of cells. However, the high cost of cellular experiments and single-cell sequencing restrict us from measuring the full combination space of genetic perturbations and cell types. Consequently, a bunch of computational models have been proposed to predict unseen combinations based on existing data. Among them, generative models, e.g. variational autoencoder and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39584702/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1x5bM_TNL8gjogAcnslpo2s2PbDe-61JVM2h9yowOYSiZ7Dkrt&amp;fc=20220919211934&amp;ff=20241126171715&amp;v=2.18.0.post9&#43;e462414">BioDSNN: a dual-stream neural network with hybrid biological knowledge integration for multi-gene perturbation response prediction</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39584702-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1x5bm-tnl8gjogacnslpo2s2pbde-61jvm2h9yowoysiz7dkrt-fc-20220919211934-ff-20241126171715-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Studying the outcomes of genetic perturbation based on single-cell RNA-seq data is crucial for understanding genetic regulation of cells. However, the high cost of cellular experiments and single-cell sequencing restrict us from measuring the full combination space of genetic perturbations and cell types. Consequently, a bunch of computational models have been proposed to predict unseen combinations based on existing data. Among them, generative models, e.g. variational autoencoder and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39584774/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241125170918&amp;v=2.18.0.post9&#43;e462414">Too Big to Fail: Volumetric Analyses and Incidence of Posthepatectomy Liver Failure in 125 Major Hepatectomies in Children</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39584774-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241125170918-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: This is the largest reported single-center series of pediatric major hepatectomies. PHLF is exceedingly rare in children. The liver volume-to-body weight ratio is higher in children compared to adults, and the FLR is sufficient even in extreme resections with less than 20% of liver remnant. These findings strongly question the use of ALPPS, portal vein embolization, or transplantation based on suspected insufficient liver remnant in &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39585318/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241125170918&amp;v=2.18.0.post9&#43;e462414">Childhood, adolescent and young adulthood cancer risk in BRCA1 or BRCA2 pathogenic variant carriers</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39585318-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241125170918-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: We found no evidence that BRCA1/2 PV carriers have an increased CAYA cancer risk aside from breast cancer in women in their 20&rsquo;s. Our results, along with a critical evaluation of previous germline sequencing studies, suggest that the childhood and adolescent cancer risk conferred by BRCA1/2 PV would be low (ie, RR &lt; 2) if it existed. Our findings do not support PV testing for offspring of BRCA1/2 PV carriers at ages &lt;18 years, nor for conducting BRCA1/2 PV testing for childhood &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39585362/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241125170918&amp;v=2.18.0.post9&#43;e462414">Goodbye-Valued members of the German Society for Neurology</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39585362-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241125170918-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39585427/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241125170918&amp;v=2.18.0.post9&#43;e462414">Change to outpatient treatment in surgery</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39585427-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241125170918-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39585484/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20241125170912&amp;v=2.18.0.post9&#43;e462414">Advances in Primary Central Nervous System Lymphoma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39585484-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20241125170912-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    PURPOSE OF REVIEW: Optimal initial management can have a significant impact in long-term outcome in primary CNS lymphoma. This article reviews recent advances and the state of the &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39585484/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20241126171712&amp;v=2.18.0.post9&#43;e462414">Advances in Primary Central Nervous System Lymphoma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39585484-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20241126171712-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    PURPOSE OF REVIEW: Optimal initial management can have a significant impact in long-term outcome in primary CNS lymphoma. This article reviews recent advances and the state of the &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39585736/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241125170918&amp;v=2.18.0.post9&#43;e462414">Noisy neuronal populations effectively encode sound localization in the dorsal inferior colliculus of awake mice</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39585736-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241125170918-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Sound location coding has been extensively studied at the central nucleus of the mammalian inferior colliculus (CNIC), supporting a population code. However, this population code has not been extensively characterized on the single-trial level with simultaneous recordings or at other anatomical regions like the dorsal cortex of inferior colliculus (DCIC), which is relevant for learning-induced experience dependent plasticity. To address these knowledge gaps, here we made in two &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39587047/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241126171718&amp;v=2.18.0.post9&#43;e462414">Interferential Current Stimulation of Rectal Motor Activity - Objective Data from the Isolated Perfused Porcine Rectum</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39587047-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241126171718-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: IFCd5-25 stimulates rectal motor activity in the isolated perfused porcine rectum. Ganglia in the enteric nervous system are modulated to allow increased activity throughout at least 30min. Therefore, the isolated porcine rectum is a suitable tool to study the effectiveness of various IFC settings in the &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39587067/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241126171718&amp;v=2.18.0.post9&#43;e462414">Critical assessment of LC3/GABARAP ligands used for degrader development and ligandability of LC3/GABARAP binding pockets</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39587067-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241126171718-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Recent successes in developing small molecule degraders that act through the ubiquitin system have spurred efforts to extend this technology to other mechanisms, including the autophagosomal-lysosomal pathway. Therefore, reports of autophagosome tethering compounds (ATTECs) have received considerable attention from the drug development community. ATTECs are based on the recruitment of targets to LC3/GABARAP, a family of ubiquitin-like proteins that presumably bind to the autophagosome &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39587170/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241126171718&amp;v=2.18.0.post9&#43;e462414">A biocompatible supramolecular hydrogel mesh for sample stabilization in light microscopy and nanoscopy</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39587170-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241126171718-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Most embedding media for live and fixed samples were not designed for microscopy and have issues including long polymerization times, peak of toxicity toward the sample during the sol-gel transition, and irreversibility of this transition. Gels derived from biological sources are widely used in microscopy, but their precise composition is ill-defined and can vary between batches. Non-physiological temperatures and/or specific enzymatic solutions are often needed to revert the gel back to the &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1655755343/P1U06uB69">11æœˆ16ä¸‡å­—çš„ä½œä¸šï¼Œä¸‹åˆæ’é˜Ÿçœ‹ç‰™çš„æ—¶å€™çœ‹å§[æ±—]ğŸ¦· [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-25</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1655755343-p1u06ub69/">
    
    
    
    
    
      
    
    11æœˆ16ä¸‡å­—çš„ä½œä¸šï¼Œä¸‹åˆæ’é˜Ÿçœ‹ç‰™çš„æ—¶å€™çœ‹å§<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ğŸ¦· <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/2103074805/P1Vy0ecYt">[å¿ƒ] - è½¬å‘ @Liz_Catmilk1121:&amp;ensp;Liz ğŸ±#liz1121ç”Ÿæ—¥å¿«ä¹# ã€241122 é¥­åˆ¶åŠ¨å›¾ã€‘cr. sakana_uo33ioÂ°. â‘…â™¡â‘… Â°. &#43;. Â°. â‘…â™¡â‘… Â°. &#43;. Â°. â‘…â™¡â‘… Â°.ï¿½...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-25</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-2103074805-p1vy0ecyt/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@Liz_Catmilk1121<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/2103074805/P1ZGD0teA">å¾ˆçƒ¦é‚£ç§â€œæˆ‘è§‰å¾—ä¸å€¼æ‰€ä»¥æˆ‘è¦è´¬ä½ä½ åšçš„äº‹â€çš„äººã€‚æœ‰æ²¡æœ‰ä¸€ç§å¯èƒ½ï¼Œä½ ç‰¹ä¹ˆè°å•Š[å˜»å˜»][å˜»å˜»][å˜»å˜»]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-25</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-2103074805-p1zgd0tea/">
    
    
    
    
    
      
    
    å¾ˆçƒ¦é‚£ç§â€œæˆ‘è§‰å¾—ä¸å€¼æ‰€ä»¥æˆ‘è¦è´¬ä½ä½ åšçš„äº‹â€çš„äººã€‚æœ‰æ²¡æœ‰ä¸€ç§å¯èƒ½ï¼Œä½ ç‰¹ä¹ˆè°å•Š<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img alt=&quot;[å˜»å˜»]&quot; src=&ldquo;<a href="https://h5.sinaimg.cn/m/emoticon/icon/default/d_xixi-643ef6e48d.png%22">https://h5.sinaimg.cn/m/emoticon/icon/default/d_xixi-643ef6e48d.png&quot;</a> style=&ldquo;width:1em; height:1em;&rdquo; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/P1UM8a2vy">æ—¥æœ¬äººå–å†·æ°´ï¼Œä½†å…³è¥¿ç©ºæ¸¯æœ‰å…è´¹çƒ­æ°´[èµ][èµ][èµ]æˆ‘è®°å¿†ä¸­ï¼Œå¤–å›½å€™æœºæ¥¼æœ‰å…è´¹çƒ­æ°´ä¾›åº”çš„åªæœ‰æ–°åŠ å¡å’ŒèŠ¬å…°æœºåœºã€‚ æ—¥æœ¬Â·é–¢è¥¿å›½éš›ç©ºæ¸¯ (Kansai International Airp...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-25</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-p1um8a2vy/">
    
    
    
    
    
      
    
    æ—¥æœ¬äººå–å†·æ°´ï¼Œä½†å…³è¥¿ç©ºæ¸¯æœ‰å…è´¹çƒ­æ°´<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æˆ‘è®°å¿†ä¸­ï¼Œå¤–å›½å€™æœºæ¥¼æœ‰å…è´¹çƒ­æ°´ä¾›åº”çš„åªæœ‰ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/P1YCjxR8Q">ä»Šå¤©åœ¨å¤§é˜ªå…³è¥¿å›½é™…ç©ºæ¸¯å…ç¨åº—ï¼Œå–µå¥¶å¥¶ç¡¬è¦ä¹°ä¸¤ç“¶1677å¹´åˆ›ä¸šçš„æ—¥æœ¬æ¸…é…’â€œç¥åœ£â€ï¼Œè®©å–µçˆ·çˆ·åœ¨ç¦å·æ…¢æ…¢å“å‘³ã€‚è¯¥é…’åˆ†å››ä¸ªæ¡£æ¬¡ï¼Œå…ç¨ä»·æ ¼ç”±ä½åˆ°é«˜ï¼Œ3100ï¼Œ5500ï¼Œ1000...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-25</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-p1ycjxr8q/">
    
    
    
    
    
      
    
    ä»Šå¤©åœ¨å¤§é˜ªå…³è¥¿å›½é™…ç©ºæ¸¯å…ç¨åº—ï¼Œå–µå¥¶å¥¶ç¡¬è¦ä¹°ä¸¤ç“¶1677å¹´åˆ›ä¸šçš„æ—¥æœ¬æ¸…é…’â€œç¥åœ£â€ï¼Œè®©å–µçˆ·çˆ·åœ¨ç¦å·æ…¢æ…¢å“å‘³ã€‚è¯¥é…’åˆ†å››ä¸ªæ¡£æ¬¡ï¼Œå…ç¨ä»·æ ¼ç”±ä½åˆ°é«˜ï¼Œ3100ï¼Œ5500ï¼Œ10000ï¼Œ19900ã€‚æˆ‘é€‰æ‹©æœ€ä½æ¡£æ¬¡ï¼ŒæŠ˜åˆäººæ°‘å¸148å…ƒã€‚æ™šé¤åå›åˆ°é…’åº—ï¼Œæ‰“å¼€ä¸€ç“¶ï¼Œè‡ªæ–Ÿè‡ªé¥®ã€‚å–µå¥¶å¥¶è¯´è‡ªè§‰ä¸€ç‚¹å“ˆï¼æ„æ€æ˜¯ï¼Œä¸è¦å–å¤šäº†ã€‚æˆ‘è¯´å°±ä¸€ç“¶æ¸…é…’ï¼Œå¥½å¤§ä¸ªç”·å¥³å…³ç³»å˜›ï¼æˆ‘åŠªåŠ›äº‰å–ä¸å–å®Œã€‚å–é…’çš„äººéƒ½çŸ¥é“ï¼Œæ—¥æœ¬æ¸…é…’è·Ÿç»å…´èŠ±é›•ä¸€æ ·ï¼Œé…’ç²¾åº¦13Â°-16Â°ï¼Œå±äºä½åº¦é…’ï¼Œä¸é†‰äººã€‚ä½†é…’ä¸é†‰äººäººè‡ªé†‰ï¼Œä¸€è¾¹å“é…’ä¸€è¾¹å›å‘³äººç”Ÿï¼Œäººç”Ÿæœ€é‡è¦çš„ï¼šæ‰¾åˆ°ä¸‰è§‚ä¸å°½ç›¸åŒå´èƒ½äº’ç›¸æ¬£èµçš„ç»ˆèº«ä¼´ä¾£ã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_small_location_default.png%22">https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_small_location_default.png&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/P1Yj3acjV">åˆå3ï¼š12ï¼Œå¦èˆªç­æœºé™è½ç¦å·é•¿ä¹æœºåœºã€‚æœºåœºè·å¸‚åŒº50å¤šå…¬é‡Œï¼Œè¿˜æ²¡é€šåœ°é“æˆ–è½»è½¨ï¼Œåæœºåœºå¤§å·´åˆ°è¾¾å¸‚åŒºï¼Œ5ï¼š30å·¦å³ï¼Œå¤©å·²é»‘äº†ã€‚æˆ‘ä»¬æ˜¯ç¬¬ä¸€æ¬¡æ¥ç¦å·ï¼Œäººç”Ÿåœ°ä¸ç†Ÿï¼Œå«...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-25</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-p1yj3acjv/">
    
    
    
    
    
      
    
    åˆå3ï¼š12ï¼Œå¦èˆªç­æœºé™è½ç¦å·é•¿ä¹æœºåœºã€‚æœºåœºè·å¸‚åŒº50å¤šå…¬é‡Œï¼Œè¿˜æ²¡é€šåœ°é“æˆ–è½»è½¨ï¼Œåæœºåœºå¤§å·´åˆ°è¾¾å¸‚åŒºï¼Œ5ï¼š30å·¦å³ï¼Œå¤©å·²é»‘äº†ã€‚æˆ‘ä»¬æ˜¯ç¬¬ä¸€æ¬¡æ¥ç¦å·ï¼Œäººç”Ÿåœ°ä¸ç†Ÿï¼Œå«ç½‘çº¦è½¦å»é…’åº—ã€‚è·¯ä¸Šé—®å¸æœºç¦å·æœ‰ä»€ä¹ˆç¾é£Ÿï¼Ÿå¸æœºè¯´ä½ ä»¬è‚¯å®šä¸å–œæ¬¢åƒã€‚å–µå¥¶å¥¶æ¯”æˆ‘è¿˜æ‰æ€¥ï¼Œå¥¹è¯´ä¸ºä»€ä¹ˆï¼Ÿå¸æœºè¯´åç”œã€‚æˆ‘è¯´ä¸å¯èƒ½éƒ½åç”œå§ï¼Ÿå–µå¥¶å¥¶è¯´ä½ å…·ä½“è¯´è¯´ç¦å·äººæœ€å–œæ¬¢åƒä»€ä¹ˆèœå§ã€‚å¸æœºè¯´æœ‰å®¶è€è™ç²¥ï¼Œè·ä½ ä»¬çš„é…’åº—ä¸è¿œã€‚è€è™ç²¥è®©æˆ‘æƒ³èµ·ä¸œåŒ—è€è™èœï¼Œæˆéƒ½äººä¹Ÿå¾ˆå–œæ¬¢ã€‚å–µå¥¶å¥¶ååº”æ¯”æˆ‘å¿«ï¼Œå¥¹è¯´è€è™ç²¥â€”â€”å‘µå‘µï¼Œè€ç¦å·ï¼Œéƒ½æœ‰ä»€ä¹ˆï¼Ÿå¸æœºè¯´ä½ ä»¬å»å°±çŸ¥é“äº†ã€‚<!-- raw HTML omitted --> åˆ°é…’åº—æŠŠè¡Œæå®‰é¡¿å¥½ï¼Œé«˜å¾·åœ°å›¾æœä¸€æœï¼Œè€ç¦å·å¾è®°ï¼Œæ­¥è¡Œ600ç±³å³åˆ°ã€‚é«˜å¾·ç¾å¥³å¯¼èˆªï¼Œèµ°å…¥ææ€–ä¹‹è·¯ï¼Œè¶Šèµ°è¶Šé»‘ï¼Œè¶Šèµ°è¶Šé™¡ã€‚ç¦å·åˆšä¸‹è¿‡é›¨ï¼Œè·¯æ˜¯æ»‘çš„ï¼Œç”Ÿæ€•å–µå¥¶å¥¶æ‘”å€’å´´è„šï¼Œè·é¤å…è¿˜æœ‰120å¤šç±³çš„æ—¶å€™ï¼Œå½“æœºç«‹æ–­ï¼Œä¸åƒè¿™ä¸ªè€è™ç²¥ï¼Œæ‰¶ç€å–µå¥¶å¥¶ï¼ŒåŸè·¯è¿”å›ã€‚æˆ‘è¯´å°±åœ¨é…’åº—é™„è¿‘æ‰¾å®¶é¤é¦†éšä¾¿åƒç‚¹ä»€ä¹ˆï¼Ÿå–µå¥¶å¥¶è¯´å®åœ¨æ‰¾ä¸åˆ°é¤é¦†ä¹Ÿæ— æ‰€è°“ï¼Œæˆ‘èƒŒåŒ…é‡Œè¿˜æœ‰ä»å¤§é˜ªä¹°çš„é¢åŒ…ï¼Œå¯ä»¥åƒã€‚æˆ‘è¯´å¤©å•Šï¼Œå¤§é˜ªæ²¡åƒå®Œçš„ä¸¤ç‰‡é¢åŒ…ï¼Œä½ ç«Ÿç„¶åƒé‡Œè¿¢è¿¢å¸¦å›å›½é—¨ï¼Ÿå¹¸å¥½æµ·å…³æ²¡æŸ¥ä½ ã€‚å¥¹è¯´çˆªå­å˜›ï¼Ÿæµ·å…³æŸ¥æˆ‘ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/P1Zhqbbun">å–µå¥¶å¥¶è¯´å¦‚æœä½ ä¸å–é…’ï¼Œå°±æ˜¯ä¸–ç•Œä¸Šæœ€å¥½çš„ç”·äººã€‚æˆ‘è¯´å¦‚æœæˆ‘ä¸å–é…’ï¼Œå°±æ˜¯ä¸–ç•Œä¸Šæœ€æ— è¶£çš„ç”·äººã€‚å–µçˆ·çˆ·çš„é…’æ•…äº‹å¾ˆå¤šï¼Œé…’èƒ½ä¹±æ€§ï¼Œå–µå¥¶å¥¶å¼•ä»¥ä¸ºè€»ï¼Œè¶Šè¯´è¶Šæ°”æ„¤ï¼Œè®©å–µçˆ·...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-25</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-p1zhqbbun/">
    
    
    
    
    
      
    
    å–µå¥¶å¥¶è¯´å¦‚æœä½ ä¸å–é…’ï¼Œå°±æ˜¯ä¸–ç•Œä¸Šæœ€å¥½çš„ç”·äººã€‚æˆ‘è¯´å¦‚æœæˆ‘ä¸å–é…’ï¼Œå°±æ˜¯ä¸–ç•Œä¸Šæœ€æ— è¶£çš„ç”·äººã€‚å–µçˆ·çˆ·çš„é…’æ•…äº‹å¾ˆå¤šï¼Œé…’èƒ½ä¹±æ€§ï¼Œå–µå¥¶å¥¶å¼•ä»¥ä¸ºè€»ï¼Œè¶Šè¯´è¶Šæ°”æ„¤ï¼Œè®©å–µçˆ·çˆ·è‡ªæˆ‘æ£€è®¨ï¼Œæ·±åˆ»åçœã€‚å–µçˆ·çˆ·å”¯å”¯ï¼Œä¸€ä¸å°å¿ƒï¼ŒæŠŠä¸€ç“¶1667å¹´åˆ›ä¸šçš„æ—¥æœ¬æ¸…é…’åº•æœå¤©ã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ç¦å·Â·ç¦å·ä¸‰åŠä¸ƒå··ä¹Œå±±è·¯äºšæœµé…’åº—<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/large/d1840ee6gy1hvyvy6ik5qj22bc33">https://tvax4.sinaimg.cn/large/d1840ee6gy1hvyvy6ik5qj22bc33</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/P1XtY1UrO">éƒ½æ˜¯å·±å·³å¹´çš„ï¼Œæ±‚å¹´é¾„å·® [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-25</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-p1xty1uro/">
    
    
    
    
    
      
    
    éƒ½æ˜¯å·±å·³å¹´çš„ï¼Œæ±‚å¹´é¾„å·® <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/P21U5gq1N">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œ ä¹ƒæœ¨å‚46 2025å¹´ç¦è¢‹æœŸåˆ«éšæœºé™„å¸¦ä¸ªåˆ«ç•™è¨€æ¿ğŸ™Œä¹…ä¿é…±è¯·åšè¿™ä¸ªåŠ¨ä½œğŸ–ğŸ˜®#ä¹ƒæœ¨å‚46ç¦è¢‹2025 [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-25</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-p21u5gq1n/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->ä¹ƒæœ¨å‚46 2025å¹´ç¦è¢‹<!-- raw HTML omitted --><!-- raw HTML omitted -->æœŸåˆ«éšæœºé™„å¸¦<!-- raw HTML omitted -->ä¸ªåˆ«ç•™è¨€æ¿ğŸ™Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿é…±<!-- raw HTML omitted -->è¯·åšè¿™ä¸ªåŠ¨ä½œ<!-- raw HTML omitted --><!-- raw HTML omitted -->ğŸ–<!-- raw HTML omitted -->ğŸ˜®<!-- raw HTML omitted -->&lt; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/P21U7oTDu">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œ via.å‘äº•å¶æœˆ blog [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-25</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-p21u7otdu/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --> via.å‘äº•å¶æœˆ blog &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/006z6nxLgy1hvyqs3nyndj30zk0qodn0.jpg%22">https://tvax2.sinaimg.cn/large/006z6nxLgy1hvyqs3nyndj30zk0qodn0.jpg&quot;</a>  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/P21Ual74s">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œã€ ç¡è§‰çš„ç¬¨è›‹ã€å‰§ç…§ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-25</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-p21ual74s/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->ã€ ç¡è§‰çš„ç¬¨è›‹ã€å‰§ç…§ &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/006z6nxLgy1hvytpi17qdj335s23vhdt.jpg%22">https://tvax3.sinaimg.cn/large/006z6nxLgy1hvytpi17qdj335s23vhdt.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/P21UejmH5">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œ ã€è¢«æœªæ¥çš„æˆ‘æš´å‡»ã€å‰§ç…§ [å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-25</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-p21uejmh5/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --> ã€è¢«æœªæ¥çš„æˆ‘æš´å‡»ã€å‰§ç…§ &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/006z6nxLgy1hvytpz2k4lj30zk0k0q9z.jpg%22">https://tvax2.sinaimg.cn/large/006z6nxLgy1hvytpz2k4lj30zk0k0q9z.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/P21UfucCP">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œ via.nhk_dramas [å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-25</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-p21ufuccp/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --> via.nhk_dramas &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/006z6nxLgy1hvyx9qy4pwj30k00p0q63.jpg%22">https://tvax1.sinaimg.cn/large/006z6nxLgy1hvyx9qy4pwj30k00p0q63.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/P21UIyjo5">åˆç»™æˆ‘æ¡åˆ°åƒåœ¾äº†è¯´æ˜¯[å¹é£è½¦]justiceâ€”â€”ğŸ¤˜ğŸ» [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-25</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-p21uiyjo5/">
    
    
    
    
    
      
    
    åˆç»™æˆ‘æ¡åˆ°åƒåœ¾äº†è¯´æ˜¯<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->justiceâ€”â€”ğŸ¤˜ğŸ» <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/P1TBsu86x">8å·çº¿å¤§ä¸–ç•Œç«™å‘ç”Ÿå•¥äº‹äº†ï¼Ÿ@ä¸Šæµ·åœ°é“shmetro</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-25</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-p1tbsu86x/">
    
    
    
    
    
      
    
    8å·çº¿å¤§ä¸–ç•Œç«™å‘ç”Ÿå•¥äº‹äº†ï¼Ÿ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->@ä¸Šæµ·åœ°é“shmetro<!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/P1ZeUncJG">å‘å¸ƒäº†å¤´æ¡æ–‡ç« ï¼šã€Šæ‰€æœ‰çš„èµ·ç‚¹å§‹äºå›´æ£‹â€”â€”å¾·ç±³æ–¯Â·å“ˆè¨æ¯”æ–¯é€ è®¿æ—¥æœ¬æ£‹é™¢ã€‹ #å›´æ£‹# å›´æ£‹ æ‰€æœ‰çš„èµ·ç‚¹å§‹äºå›´æ£‹â€”â€”å¾·ç±³æ–¯Â·å“ˆè¨æ¯”æ–¯é€ è®¿æ—¥æœ¬æ£‹é™¢ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-25</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-p1zeuncjg/">
    
    
    
    
    
      
    
    å‘å¸ƒäº†å¤´æ¡æ–‡ç« ï¼šã€Šæ‰€æœ‰çš„èµ·ç‚¹å§‹äºå›´æ£‹â€”â€”å¾·ç±³æ–¯Â·å“ˆè¨æ¯”æ–¯é€ è®¿æ—¥æœ¬æ£‹é™¢ã€‹ <!-- raw HTML omitted --><!-- raw HTML omitted -->#å›´æ£‹#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->å›´æ£‹<!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/P1Xyk04eB">ä¹…ä¿å²ç»ªé‡Œ via.venue101 [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-25</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-p1xyk04eb/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --> via.venue101 <!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/006z6nxLgy1hvyonfngezj31400u0">https://tvax2.sinaimg.cn/large/006z6nxLgy1hvyonfngezj31400u0</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/P1Y1o5Jcl">ä¹…ä¿å²ç»ªé‡Œ ä¹ƒæœ¨å‚46 2025å¹´ç¦è¢‹æœŸåˆ«éšæœºé™„å¸¦ä¸ªåˆ«ç•™è¨€æ¿ğŸ™Œä¹…ä¿é…±è¯·åšè¿™ä¸ªåŠ¨ä½œğŸ–ğŸ˜®#ä¹ƒæœ¨å‚46ç¦è¢‹2025 [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-25</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-p1y1o5jcl/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->ä¹ƒæœ¨å‚46 2025å¹´ç¦è¢‹<!-- raw HTML omitted --><!-- raw HTML omitted -->æœŸåˆ«éšæœºé™„å¸¦<!-- raw HTML omitted -->ä¸ªåˆ«ç•™è¨€æ¿ğŸ™Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿é…±<!-- raw HTML omitted -->è¯·åšè¿™ä¸ªåŠ¨ä½œ<!-- raw HTML omitted --><!-- raw HTML omitted -->ğŸ–<!-- raw HTML omitted -->ğŸ˜®<!-- raw HTML omitted --><!-- raw HTML omitted -->#ä¹ƒæœ¨å‚46ç¦è¢‹2025 &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/large/006z6nxLgy1hvyqfj0erjj30m80m8q">https://tvax4.sinaimg.cn/large/006z6nxLgy1hvyqfj0erjj30m80m8q</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/P1Y2dbMxt">ä¹…ä¿å²ç»ªé‡Œ via.å‘äº•å¶æœˆ blog [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-25</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-p1y2dbmxt/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --> via.å‘äº•å¶æœˆ blog <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/P1YHEa3U5">ä¹…ä¿å²ç»ªé‡Œ ã€è¢«æœªæ¥çš„æˆ‘æš´å‡»ã€å‰§ç…§ [å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-25</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-p1yhea3u5/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --> ã€è¢«æœªæ¥çš„æˆ‘æš´å‡»ã€å‰§ç…§ <!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/006z6nxLgy1hvytpzk4">https://tvax2.sinaimg.cn/large/006z6nxLgy1hvytpzk4</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/P1YHqyknu">ä¹…ä¿å²ç»ªé‡Œã€ ç¡è§‰çš„ç¬¨è›‹ã€å‰§ç…§ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-25</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-p1yhqyknu/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->ã€ ç¡è§‰çš„ç¬¨è›‹ã€å‰§ç…§ <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/P1ZvtuXd3">ä¹…ä¿å²ç»ªé‡Œ via.nhk_dramas [å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-25</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-p1zvtuxd3/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --> via.nhk_dramas <!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/006z6nxLgy1hvyx9rap74j30k0">https://tvax3.sinaimg.cn/large/006z6nxLgy1hvyx9rap74j30k0</a> &hellip;
    </a>
  </div>
</section>

</main>
</div>

<script async src="//yihui.name/js/center-img.js"></script>

<footer>

<div class="footer">
  <ul class="menu">
    
    <li><a href="/"><span data-hover="Home">Home</span></a></li>
    
    <li><a href="/about/"><span data-hover="About">About</span></a></li>
    
    <li><a href="/archives/"><span data-hover="Archive">Archive</span></a></li>
    
    <li><a href="/contributor/"><span data-hover="Contributor">Contributor</span></a></li>
    
    <li><a href="/index.xml"><span data-hover="Subscribe">Subscribe</span></a></li>
    
  </ul>
  
  <div class="copyright">Â© <a href="https://rainoffallingstar.github.io">Fallingstar</a> 2023 | <a href="https://github.com/rainoffallingstar">Github</a></div>
  
</div>
</footer>







</body>
</html>

